去年，Integer Holdings Corp表现最佳的业务板块Cardio & Vascular实现营收1.11B美元。United States的营收贡献最高，去年达到979.81M美元。最近一个季度，截至2026-07-03，Integer Holdings Corp表现最佳的业务板块Cardio & Vascular实现营收280.31M美元。United States的营收贡献最高，达到245.98M美元。

业务

营业收入

占比

年报

年报

单季报

Cardio & Vascular

Cardiac Rhythm Management & Neuromodulation

Advanced Surgical, Orthopedics & Portable Medical

Cardiac & Neuromodulation

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Cardio & Vascular

1.11B(59.72%)

949.58M(55.32%)

836.34M(53.84%)

699.47M(52.61%)

626.01M(52.93%)

569.95M(54.91%)

610.06M(50.85%)

Cardiac Rhythm Management & Neuromodulation

668.80M(36.08%)

660.61M(38.48%)

--(--)

Advanced Surgical, Orthopedics & Portable Medical

77.75M(4.19%)

106.41M(6.20%)

106.42M(6.85%)

97.50M(7.33%)

110.04M(9.31%)

121.79M(11.73%)

132.43M(11.04%)

Cardiac & Neuromodulation

--(--)

610.58M(39.31%)

532.58M(40.06%)

446.57M(37.76%)

346.24M(33.36%)

457.19M(38.11%)

地区

营业收入

占比

年报

年报

单季报

United States

Rest of the world

Costa Rica

Puerto Rico

Ireland

United Kingdom

Foreign Countries/All Other

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

United States

979.81M(52.86%)

938.67M(54.68%)

872.93M(56.11%)

762.44M(55.41%)

665.92M(54.54%)

596.80M(55.60%)

698.47M(55.52%)

Rest of the world

469.88M(25.35%)

516.17M(30.07%)

452.82M(29.11%)

609.00M(44.26%)

555.16M(45.46%)

--(--)

Costa Rica

173.52M(9.36%)

124.69M(7.26%)

108.42M(6.97%)

--(--)

58.85M(5.48%)

63.63M(5.06%)

Puerto Rico

131.26M(7.08%)

137.06M(7.98%)

121.49M(7.81%)

--(--)

96.05M(8.95%)

154.64M(12.29%)

Ireland

99.16M(5.35%)

--(--)

United Kingdom

--(--)

4.65M(0.34%)

--(--)

Foreign Countries/All Other

--(--)

321.74M(29.97%)

341.34M(27.13%)